Literature DB >> 31698834

Chemical Composition and Antimicrobial Activity of Artemisia herba-alba and Origanum majorana Essential Oils from Morocco.

Ghita Amor1,2, Lucia Caputo3, Antonietta La Storia2, Vincenzo De Feo3, Gianluigi Mauriello2, Taoufiq Fechtali1.   

Abstract

Essential oils (EOs) are one of the most important groups of plant metabolites responsible for their biological activities. This study was carried out to study the chemical composition and the antimicrobial effects of Artemisia herba-alba and Origanum majorana essential oils against some Gram-positive and Gram-negative bacteria, and a fungal strain isolated from spoiled butter. The plants were collected in the region Azzemour of South West Morocco and the EOs, extracted by hydrodistillation, were analyzed by GC-MS. The antimicrobial activity was determined using the agar paper disc method. The main components of A. herba-alba EO were cis-thujone, trans-thujone and vanillyl alcohol; in O. majorana EO terpinen-4-ol, isopulegol and β-phellandrene predominated. Both essential oils exhibited growth inhibiting activities in a concentration-dependent manner on several microorganism species. Our results demonstrated that O. majorana and A. herba-alba EOs could be effective natural antibacterial agents in foods.

Entities:  

Keywords:  Artemisia herba-alba; Origanum majorana; antimicrobial activity; chemical characterization; essential oils

Mesh:

Substances:

Year:  2019        PMID: 31698834      PMCID: PMC6891654          DOI: 10.3390/molecules24224021

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Essential oils (EOs) are complex mixtures derived from various parts of plants with strong aromatic components such as terpenes. They are used in many fields such as medicine, cosmetic, and food industry [1,2]. The available literature reported that EOs possess, among others, significant antiseptic, antibacterial, antiviral, antioxidant, anti-parasitic, antifungal, and insecticidal activities [3]. At the moment, Morocco is considered as one of the principal suppliers and producers of some aromatic plants, such as Artemisia herba-alba Asso, Mentha pulegium L., Lavandula stoechas L., and Rosmarinus officinalis L. Moreover, these plants produce very high added value products contributing to the economic development of Morocco [4]. Artemisia herba-alba, chih in Arabic, belongs to the Asteraceae family; its essential oil is known for its antimicrobial, antioxidant, insecticidal, and antispasmodic activities. It is also used in traditional medicine as an antispasmodic and in treatment of diabetes mellitus [2,5]. Origanum majorana L. is a lamiaceous species, known for its antimicrobial, antioxidant, antidiabetic, and antitumoral activities [6]. In traditional medicine, the plant is used as an antiepileptic and a sedative drug [7]. The aim of the present study was to identify the components of A. herba-alba and O. majorana EOs from Morocco, and to evaluate their antimicrobial activity, against some Gram-positive and Gram-negative bacteria, and their antifungal efficacy.

2. Results

2.1. Essential Oil Yields and Composition

Hydrodistillation of the aerial parts of A. herba alba and of O. majorana resulted in pale yellow oils in 0.86% and 0.97% yield, on a dry mass basis, respectively. Table 1 and Table 2 report the percent composition of the essential oils; compounds are listed according to their elution on a HP-5MS column. Fifty-eight compounds were identified, 14 for A. herba-alba, and 44 for O. majorana, accounting for 97.6% and 97.8% of the total oil, respectively. In the essential oil from A. herba-alba cis-thujone (25.5%), trans-thujone (17.7%), vanillyl alcohol (11.5%), and nor-davanone (7.8%) are the main components. In the essential oil from O. majorana, terpinen-4-ol (34.1%), α-terpinene (19.2%), and terpineol (8.9%) are the main constituents.
Table 1

Chemical composition of Artemisia herba-alba essential oil.

Compound%Ki aKi bIdentification c
trans-Arbusculone4.51048 1,2
cis-Thujone25.5107911021,2,3
trans-Thujone17.7111111141,2,3
Camphor4.9115011461,2,3
nor-Davanone7.8120012311,2
cis-Chrysanthenylacetate4.7123112651,2
Undec-10-en-1-al1.3126112961,2
CyclosativeneT134213681,2
cis, threo-Davanafuran5.8138614151,2
Vanillyl Alcohol11.5142414471,2
n-Dodecanol3.1144514701,2
Isobornyl n-butyrate4.9146614911,2
<E>-Jasmolactone3.4148314911,2
Artedouglasia Oxide C2.5149615231,2
Total 97.6
Oxygenated monoterpene56.4
Oxygenated sesquiterpenes2.5
Other compounds38.7

a Kovats retention index on HP-5 MS column; b Kovats retention index on HP Innovax column; c Identification: 1 = Kovats retention index, 2 = mass spectrum, 3 = co-injection with pure compound; T = traces, less than 0.05%.

Table 2

Chemical composition of Origanum majorana essential oil.

Compound%KI aKI bIdentification c
α-Pinene4.19419321,2,3
p-Cymene2.695010241,2,3
iso-Sylvestrene0.695210081,2,3
β-Pinene0.29759741,2,3
α-Phellandrene2.698410021,2,3
δ-3-Carene1.9100810111,2
α-Terpinene19.2102110171,2,3
Limonene0.1103810291,2,3
1,8 Cineole3.0104710311,2,3
β-Ocimene0.1106110371,2,3
cis-Sabinene hydrate1.3107010701,2
Terpinen-4-ol34.1109611491,2,3
endo-Fenchyl-acetate9.8111412201,2
Pulegone0.7112212371,2
trans-Pinocarveol0.3114311391,2
Terpineol8.9116011331,2,3
cis-Limonene oxideT118811361,2
dihydro-Linalool0.1119111351,2
cis-VerbenolT119311411,2,3
Viridene0.1119911671,2
(E)-Isocitral0.2120511801,2
Thymol0.2121112901,2,3
Carvacrol0.3122012991,2,3
γ-Elemene0.1123313381,2,3
α-Terpinyl acetate0.8124213491,2
EugenolT127113591,2,3
Neryl acetate0.2127413611,2
α-CopaeneT127813761,2,3
Geranyl acetate0.3129313811,2,3
iso-Longifolene0.1130313901,2
(E)-Caryophillene2.1131414071,2,3
β-DuprezianeneT132114221,2
β-CedreneT132414201,2,3
β-CopaeneT132714321,2,3
α-Guaiene0.2133214391,2,3
Aromadendrene0.3133614411,2,3
allo-Aromadendrene1.3137014601,2
Valencene0.2140114961,2,3
Caryophyllene oxideT143615831,2,3
EpiglobulolT144515901,2
(-)-SpathulenolT145315781,2
β-Atlanthol1.6146416081,2,3
Rosifoliol0.1148516001,2
CubenolT149716461,2
Total97.8
Monoterpene hydrocarbons33.1
Oxygenated monoterpene57.9
Sesquiterpene hydrocarbons5.1
Oxygenated sesquiterpenes1.7

a Kovats retention index on HP-5 MS column; b Kovats retention index on HP Innovax column; c Identification: 1 = Kovats retention index, 2 = mass spectrum, 3 = co-injection with pure compound. T = traces, less than 0.05%.

2.2. Antimicrobial Activity

The antimicrobial activity of A. herba-alba and O. majorana essential oils was tested, at different concentrations, against 20 microorganisms, both Gram-positive and Gram-negative strains. Figure 1 shows a representative image of the antimicrobial activity. The EO of A. herba-alba showed inhibitory effects against 15 bacterial strains, the most sensitive being Brochothrix thermosphacta 7R1, Bacillus clausii 2226 and Salmonella Typhimurium; five strains resulted resistant to this EO: Hafnia alvei 53M, Carnobacterium maltaromaticum F1201, Carnobacterium maltaromaticum D1203, Enterococcus faecalis 226 and Enterococcus faecalis ES1 (Table 3). O. majorana essential oil showed a wider spectrum of activity as it was active against all microbial strains tested (Table 4).
Figure 1

Representative antimicrobial activity of (A) Origanum majorana essential oil against Brochothrix thermosphacta D274 at the dose of 50, 40, 20, and 15 µL (from 1 to 4, respectively) and (B) Artemisia herba-alba essential oil against Bacillus clausii 2226 at the concentrations of 20, 15, 10, and 5 µL (from 1 to 4, respectively).

Table 3

Antibacterial activity of the essential oil of A. herba-alba.

StrainControlEssential Oil
GentamicinTetracyclin5 μL10 μL15 μL20 μL
B. clausii 2226 11.0 ± 1.016.3 ± 1.510.3 ± 0.614.7 ± 0.619.7 ± 1.5 a,D24.0 ± 1.0 a,A
Br. thermosphacta 7R118.3 ± 1.519.3 ± 1.2na6.0 ± 0.06.0 ± 0.112.3 ± 0.6
Br. thermosphacta D2746.0 ± 0.08.7 ± 1.26.0 ± 0.011.7 ± 0.6 a,C14.7 ± 0.6 a,A17.7 ± 0.6 a,A
C. maltaromaticum 9P6.0 ± 0.024.3 ± 1.26.0 ± 0.09.0 ± 1.0 b11.7 ± 0.6 a12.3 ± 0.6 a
C. maltaromaticum D12036.0 ± 0.022.3 ± 0.6nananana
C. maltaromaticum F12016.0 ± 0.023.3 ± 1.5nananana
C. maltaromaticum H120110.0 ± 0.0nananana6.0 ± 0.0 A
E. coli 3214.7 ± 0.618.7 ± 1.2nana6.0 ± 0.06.0 ± 0.0
Ent. faecalis 2266.0 ± 0.09.0 ± 1.0nananana
Ent. faecalis E216.0 ± 0.014.7 ± 0.6nananana
H. alvei 53M11.7 ± 1.59.7 ± 0.6nananana
L. innocua 177025.3 ± 0.620.3 ± 1.5nanana6.0 ± 0.0
P. fragi 6P214.7 ± 0.617.0 ± 1.0na6.0 ± 0.09.3 ± 0.613.3 ± 2.1
Staph. aureus 6.0 ± 0.015.3 ± 0.6nanana6.0 ± 0.0
S. Typhimurium9.7 ± 0.612.7 ± 1.2na6.0 ± 0.014.0 ± 1.7 b17.7 ± 0.6 a,B
Serr. proteamaculans 20P12.3 ± 0.624.3 ± 1.2na6.0 ± 0.07.7 ± 0.610.3 ± 0.6
Str. salivarius 6.0 ± 0.018.7 ± 1.2na6.0 ± 0.014.0 ± 1.0 a18.3 ± 1.5 a
Staph. saprophyticus 3S24.0 ± 1.029.0 ± 3.6nana6.0 ± 0.06.0 ± 0.0
Staph. sp.ES119.3 ± 1.229.3 ± 1.2na6.0 ± 0.08.3 ± 0.610.3 ± 0.6
Staph.sp.GB121.3 ± 1.227.7 ± 2.56 ± 0.011.3 ± 1.214.7 ± 0.617 ± 1.0

Data represent the diameter inhibition (in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone. na = not active. Dunnett’s test vs. Gentamicin (a,b,c,d) or Tetracycline (A,B,C,D): a,A p < 0.0001; b,B p < 0.001; c,C p < 0.01; d,D p < 0.05. B.: Bacillus; Br.: Brochothrix; C.: Carnobacterium; E.: Enterococcus; Staph.: Staphylococcus; L.: Listeria; E.: Escherichia; H.: Hafnia; P.: Pseudomonas; S.: Salmonella; Serr.: Serratia; Str.: Streptococcus.

Table 4

Activity of the essential oil of O. majorana.

StrainControlEssential Oil
GentamicinTetracyclin5 µL10 µL15 µL20 µL40 µL50 µL
B. clausii 222611.0 ± 1.016.3 ± 1.5na6.0 ± 0.015.3 ± 0.6b23.3 ± 1.5 a,B24.7 ± 0.6 a,B28.3 ± 1.5 a,B
Br. thermosphacta D2746.0 ± 0.08.7 ± 1.210.6 ± 0.6d13.3 ± 1.2 a18.3 ± 0.6 a,B23.0 ± 1.7 a,B24.3 ± 1.2 a,B26.3 ± 1.2 a,B
Br. thermosphacta 7R118.3 ± 1.519.3 ± 1.211.3 ± 1.215.3 ± 0.618.0 ± 0.020.3 ± 0.6*20.0 ± 0.021.3 ± 0.6c,D
C. maltaromaticum 9P6.0 ± 0.024.3 ± 1.2nanana6.0 ± 0.06.0 ± 0.09.3 ± 0.6a
C.maltaromaticum H120110.0 ± 0.0na6.0 ± 0.0A6.0 ± 0.0 A8.7 ± 1.2 A9.7 ± 0.6 A9.3 ± 0.6 A9.7 ± 0.6 A
C. maltaromaticum D12036.0 ± 0.022.3 ± 0.6nanana6.0 ± 0.09.3 ± 0.6 a13.3 ± 1.5 a
C. maltaromaticum F12016.0 ± 0.023.3 ± 1.5nanana6.0 ± 0.06.0 ± 0.06.0 ± 0.0
E. coli 3214.7 ± 0.618.7 ± 1.29.7 ± 0.610.7 ± 1.217.7 ± 0.620.0 ± 0.0 a24.3 ± 1.2 a,B26.7 ± 0.6 a,B
Ent. faecalis 2266.0 ± 0.09.0 ± 1.0nanana6.0 ± 0.06.0 ± 0.19.7 ± 0.7
Ent. faecalis E216.0 ± 0.014.7 ± 0.6nanana6.0 ± 0.06.0 ± 0.06.0 ± 0.0
H. alvei 53M11.7 ± 1.59.7 ± 0.68.3 ± 0.610.3 ± 0.611.7 ± 0.6 C12.7 ± 0.6 A15.0 ± 0.0 b,A20.3 ± 0.6 a,B
L. innocua 177025.3 ± 0.620.3 ± 1.5na6.0 ± 0.09.3 ± 0.611.7 ± 0.612.3 ± 0.613.7 ± 1.5
P. fragi 6P214.7 ± 0.617.0 ± 1.0nana6.0 ± 0.06.0 ± 0.06.0 ± 0.09.3 ± 0.6
Staph. aureus 6.0 ± 0.015.3 ± 0.610.7 ± 0.6 d11.7 ± 1.5 c16.3 ± 1.5 a24.3 ± 2.1 a,B27.7 ± 0.6 a,B32.3 ± 2.5 a,B
S. Typhimurium9.7 ± 0.612.7 ± 1.27.7 ± 2.111.7 ± 0.614.0 ± 1.7 d17.3 ± 1.2 c,D23.3 ± 2.9 a,B29.7 ± 0.6 a,B
Serr.proteamaculans 20P12.3 ± 0.624.3 ± 1.2nanana6.0 ± 0.016.3 ± 1.5a19.3 ± 1.2a
Str. salivarius 6.0 ± 0.018.7 ± 1.29.7 ± 0.6 c11.3 ± 0.6 a13.0 ± 1.0 a19.3 ± 1.2 a20.7 ± 1.2 a24.3 ± 1.2 a,B
Staph. saprophyticus 3S24.0 ± 1.029.0 ± 3.69.9 ± 1.011.7 ± 0.619.3 ± 1.220.3 ± 0.621.0 ± 1.024.3 ± 1.2
Staph.sp. ES119.3 ± 1.229.3 ± 1.26.0 ± 0.06.0 ± 0.014.7 ± 7.618.7 ± 1.220.0 ± 0.021.0 ± 1.0
Staph.sp.GB121.3 ± 1.227.7 ± 2.5nana5.7 ± 0.610 ± 0.014.7 ± 0.619.3 ± 1.2

Data represent the diameter inhibition(in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone. na = not active. Dunnett’s test vs. Gentamicin (a,b,c,d) or Tetracycline (A,B,C,D): a,A p < 0.0001; b,B p < 0.001; c,C p < 0.01; d,D p < 0.05. B.: Bacillus; Br.: Brochothrix; C.: Carnobacterium; E.: Enterococcus; Staph.: Staphylococcus; L.: Listeria; E.: Escherichia; H.: Hafnia; P.: Pseudomonas; S.: Salmonella; Serr.: Serratia; Str.: Streptococcus.

Data analysis showed for the EO of A. herba-alba the same antimicrobial activity of tetracycline against Streptococcus salivarius, but higher than gentamicin, and exhibited stronger antimicrobial activity than both antibiotics against Br. thermosphacta D274, B. clausii 2226, and S. Typhimurium and lower antimicrobial activity than that of both antibiotics against Staphylococcus sp. GB1, Staphylococcus saprophyticus 3S, Escherichia coli 32, Br. thermosphacta 7R1, Staphylococcus sp. ES1, and Serratia proteamaculans 20P. On the other hand, the antimicrobial activity of O. majorana essential oil was stronger than both antibiotics against Str. salivarius, E. coli 32, Br. thermosphacta 7R1, H. alvei 53M, Salmonella sp. ES1, Br. thermosphacta D274, B. clausii 2226, Ente. faecalis 226, S. Typhimurium, and Staphylococcus aureus. The same antimicrobial activity as gentamicin was recorded against Staph. saprophyticus 3S, C. maltaromaticum H1201, C. maltaromaticum F1201, Ent. faecalis E21 and lower antimicrobial activity than both antibiotics against Staph. sp GB1 and Listeria innocua 1770.

2.3. Antifungal Activity

Table 5 reports the inhibition halos in (mm) at the dose of 20 µL of the two essential oils against Aspergillus niger isolated from the spoiled butter. This fungal strain was sensitive to both essential oils; the highest inhibitory activity was showed by A. herba-alba essential oil against A. niger. Figure 2 shows the antifungal activity of both EOs as determined in the same agar dish. However, diameters of inhibition halos were measured on two separated agar dishes.
Table 5

Antifungal activity of A. herba-alba and O. majorana essential oils.

Aspergillus niger
Artemisia herba-alba 23.6 ± 1.5
Origanum majorana 14.0 ± 1.0

Data represent the diameter inhibition (in mm). Results are the mean of three repetitions ± standard deviation (SD) of the inhibition zone.

Figure 2

Antifungal activity of A. herba-alba (1) and O. majorana (2) essential oils against Aspergillus niger at the dose of 20 µL.

3. Discussion

In our A. herba-alba essential oil oxygenated monoterpenes (57.3%) predominated, with cis-thujone (25.5%) and trans-thujone (17.7%) as the main constituents. Vanillyl alcohol (11.5%) and nor-davanone (7.8%) were in appreciable amounts. These results agree with literature on the essential oil from A. herba-alba from different countries that evidenced cis- and/or trans-thujone as the principal constituents [8,9,10]. On the other hand, other studies showed eucalyptol (32.8%) as the main constituent of the A. herba-alba EO from Iran, and caryophyllene acetate (10.75%) for a Jordanian EO [11,12]. These compounds are totally absent in our essential oil. Camphor is reported as principal component in essential oil from Algeria and Tunisia (ranging between 19.6% and 50.5%) [13,14], but it is present in a low percentage in our sample (4.9%). Moreover, other studies evidenced that davanone is one of the main constituents, with a percent greater than 10% [15,16]. In our EO, davanone and its derivative, cis, threo-davanafuran, accounted for 13.6% of the oil. Instead, this is the first report on the presence of vanillyl alcohol as one of the main constituents of this EO. Other studies reported camphor as the major component of the essential oil (17.8%–50.3%) [13,15,17,18,19] that, instead, is absent in our sample or chrysanthenone, present in our EO with its derivative, iso-chrysanthenyl acetate [20,21]. Monoterpenes predominated (91.1%) in the oil of O. majorana, both hydrocarbons and oxygenated compounds; sesquiterpenes accounted for 6.8%. The main components are terpinen-4-ol (34.1%), α-terpinene (19.2%), and terpineol (8.9%). Our results are in agreement with many studies that reported terpinen-4-ol among the principal constituents of the essential oil of O. majorana [22,23,24,25,26]. Moreover, α-terpinene was present in similar percentage (ranging from 11.08% to 12.72%) also in essential oils from Tunisia and Morocco [22,27]. Instead, in the EO from the Venuezelan Andes α-terpinene is reported in lesser percentages (3.6%) [26]. trans-Sabinene hydrate was reported as one of the principal components in other studies [28,29], in our sample its isomer was present in a low quantity (1.3%). Linalool, absent in our essential oil, is the main compound in the EO of O. majorana from Turkey with a percent of 88.01% [30]. Moreover, 4-terpinene and γ-terpinene were identified as the main components in O. majorana from Taiwan and Morocco, respectively [27,31]. Most microorganisms used in this study were sensitive to both essential oils, with the dose of 20 μL of EO sufficient to stop the growth of almost all tested Gram-positive and Gram-negative strains. In particular, O. majorana EO resulted more active, showing a wide spectrum of activity. On the other hand, the EO of A. herba-alba showed inhibitory effects against 15 bacterial strains. The available literature reports the antimicrobial activity of A. herba-alba essential oil against Staph. aureus, E. coli, and B. cereus [23,32,33]. Moreover, several studies showed a great potential of A. herba-alba EO oil as an antibacterial agent against Klebsiella pneumoniae, Listeria monocytogenes, Vibrio colerae, and S. Typhimurium [34,35,36]. Our results showed variable antimicrobial and antifungal activity of the essential oil, being the inhibition zones in the range of 10–24 mm. Gram-positive bacteria resulted more sensitive to this EO. The Gram-positive B. clausii 2226 was the most sensitive tested strain, with the strongest inhibition zone (24.00 ± 1 mm). B. clausii was used as a model of spore-forming aerobic microorganism and our findings showed that our A. herba-alba EO is suitable to control the growth of this microorganism. It is well known that spore forming bacteria (also called thermoduric) are the main problem in pasteurized foods, both from the point of view of food spoilage and human intoxication. Gram-negative strains also displayed variable degree of susceptibility to this EO. The maximum activity was showed against the pathogen strain S. Typhimurium (17.7 ± 0.6), but C. maltaromaticum F1201, C. maltaromaticum D1203, H. alvei 53M, Ent. faecalis E21, and Ent. faecalis 226 resulted resistant, since no inhibition zone was observed. Due to the involvement of S. Typhimurium in the majority of food intoxication across the world, the antimicrobial capability of this EO could be of pivotal importance in the control of this microorganism in foods. The antimicrobial activity of O. majorana essential oil appears to be similarly effective against both Gram-positive and Gram-negative microorganisms. These results agree with literature data [21,34,35]. Data of previous research showed that O. majorana essential oil was active against a large spectrum of different bacteria strains: E. coli, Str. agalactiae, Shigella dysenteriae, Salmonella Enteritidis, Staph. aureus, Ent. faecalis, E. coli, and Klebsiella pneumoniae [26,37]. In our study, all tested strains were sensitive to this essential oil, with the Gram-positive S. aureus the most sensitive with the greatest inhibition zone (32.2 ± 2.5 mm); the more sensitive Gram-negative was S. Typhimurium, with an inhibition zone of 29.7 ± 0.6 mm. The antimicrobial activity of both essential oils could be related to their content in oxygenated monoterpenes, which constitute about 57.3% and 53.0% of the EOs of A. herba alba and O. majorana, respectively. Similar findings have been already previously reported [38,39]. The major components of O. majorana EO, e.g., terpinen-4-ol, α-terpinol and α-pinene, have been reported for their antimicrobial and antifungal properties [21]. Additionally, the main constituents of the EO of A. herba-alba, cis- and trans-thujone and vanillyl alcohol, have been reported for their antimicrobial, anti-inflammatory, and antioxidant activities [40,41]. Oxygenated monoterpenes exhibit high antimicrobial activity on whole cell and possess antifungal effects. These compounds diffuse into and damage cell membrane structures [42]. Our results showed high antifungal activity for both essential oils, with the highest inhibitory activity shown by the EO of A. herba-alba against Aspergillus niger (inhibition zone 23.6 ± 1.5 mm). These results are consistent with data previously reported [29,43].

4. Materials and Methods

4.1. Plant Material

The aerial parts of A. herba-alba and O. majorana were collected in the Azzemour region, South West Morocco, in June 2018, in flowering stage, and dried in the shade. The plants were identified by Prof. V. De Feo. A voucher specimen of each plant is stored in Department of Agricultural Sciences, University of Naples Federico II.

4.2. Essential Oil Extraction

One kilogram of A. herba-alba and O. majorana aerial parts was subjected to hydrodistillation for 3 h, according to the standard procedure described in the European Pharmacopoeia [44]. The oils were solubilized in n-hexane, filtered over anhydrous sodium sulphate and stored under N2 at +4 °C in the dark, until tested and analyzed.

4.3. GC-FID Analysis

Analytical gas chromatography was carried out on a Perkin-Elmer Sigma-115 gas-chromatograph (Perkin Elmer, Waltham, MA, USA) equipped with an FID and a data handling processor. The separation was achieved using a HP-5 MS fused-silica capillary column (30 m × 0.25 mm i.d., 0.25 µm film thickness). Column temperature: 40 °C, with 5 min initial hold, and then to 270 °C at 2 °C/min, 270 °C (20 min); injection mode splitless (1 µL of a 1:1000 n-hexane solution). Injector and detector temperatures were 250 °C and 290 °C, respectively. Analysis was also run by using a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm i.d., 0.25 µm film thickness). In both cases, helium was used as carrier gas (1.0 mL/min).

4.4. GC/MS Analysis

Analysis was performed on an Agilent 6850 Ser. II apparatus (Agilent, Roma, Italy), fitted with a fused silica DB-5 capillary column (30 m × 0.25 mm i.d., 0.33 µm film thickness), coupled to an Agilent Mass Selective Detector MSD 5973 (Agilent); ionization energy voltage 70 eV; electron multiplier voltage energy 2000 V. Mass spectra were scanned in the range 40–500 amu, scan time 5 scans/s. Gas chromatographic conditions were as reported in the previous paragraph; transfer line temperature, 295 °C.

4.5. Identification of the Essential Oil Components

Most constituents were identified by comparison of their Kovats retention indices (Ri) (determined relative to the tR of n-alkanes (C10–C35), with either those of the literature [45,46,47] and mass spectra on both columns or those of authentic compounds available in our laboratories by means of NIST 02 and Wiley 275 libraries [48]. The components relative concentrations were obtained by peak area normalization.

4.6. Antibacterial Assay

The antibacterial activity was evaluated in vitro, by means of the agar diffusion test on the plate. The activity of the essential oils was tested on the 20 microorganisms reported in Table 6. All of them belong to the collection of the Department of Agricultural Sciences, University of Naples Federico II.
Table 6

Source and optimal growth conditions of microorganisms.

GramMicroorganismSourceGrowth Conditions
Positive B. clausii 2226SupplementTSB 24h at 30 °C
Br. thermosphacta 7R1MeatTSB 24h at 20 °C
Br. thermosphacta D274MeatTSB 24h at 20 °C
C. maltaromaticum 9PMeatTSB 24h at 20 °C
C. maltaromaticum D1203MeatTSB 24h at 25 °C
C. maltaromaticum F1201MeatTSB 24h at 25 °C
C. maltaromaticum H1201MeatTSB 24h at 25 °C
Ent. faecalis 226MilkTSB 24h at 30 °C
Ent. faecalis E21MilkTSB 24h at 30 °C
Staph. aureus MeatTSB 24h at 37 °C
Staph. saprophyticus 3SFermented meatTSB 24h at 37 °C
Staph. sp. ES1Fermented meatTSB 24h at 37 °C
Staph. sp. GB1Fermented meatTSB 24h at 37 °C
L. innocua 1770MilkTSB 24h at 30 °C
E. coli 32MeatTSB 24h at 37 °C
Str. salivarius MilkTSB 24h at 30 °C
Negative H.alvei 53MMeatTSB 24h at 30 °C
Pseud. fragi 6P2MeatTSB 24h at 20 °C
S. TyphimuriumChicken meatTSB 24h at 30 °C
Serr.proteamaculans20PMeatTSB 24h at 25 °C

B.: Bacillus; Br.: Brochothrix; C.: Carnobacterium; E.: Enterococcus; Staph.: Staphylococcus; L.: Listeria; E.: Escherichia; H.: Hafnia; P.: Pseudomonas; S.: Salmonella; Serr.: Serratia; Str.: Streptococcus.

Microbial strains were previously grown in TSB tryptone soya broth for 24 h. A volume of 0.1 mL of the microbial suspensions (about 1 × 108 CFU/mL) was uniformly distributed on Nutrient agar plates in sterile conditions. Different amounts of essential oils were spotted on the inoculated plates: 50, 40, 20, 15, 10, and 5 µL for O. majorana and 20, 15, 10, and 5 µL for A. herba-alba essential oils. After 10 min, under sterile conditions, plates were then incubated at optimal growth condition culture of each strain. The antimicrobial activity was evidenced by measuring the diameter (in mm) of the zone of inhibition. Ethanol was used as the negative control; tetracycline (10 µg) and gentamycin (10 µg) were used as positive controls. Each experiment was carried out in three independent replicates and result is the average with standard deviation.

4.7. Antifungal Activity

The antifungal activity was evaluated in vitro, using the agar well diffusion method on the plates. The activity was tested against Aspergillus niger isolated from a spoiled butter sample and identified by phenotypic characteristics. The fungus was previously grown in TSA agar plates at 28 °C until spore formation. Then, 1 mL of a spore suspension in quarter strength Ringer solution, containing about 1 × 108 spores per mL, was uniformly distributed on Nutrient agar plates in sterile conditions, then a hole was punched with sterile cork and 20 µL of each EO was introduced into the well; the plates were incubated at 28 °C for 4–5 days. Ethanol was used as the negative control. The antifungal activity was evaluated by measuring diameter of the inhibition area. Each experiment was carried out in three independent replicates and result is the average with standard deviation.

4.8. Statistical Analysis

Data of each experiment were statistically analyzed using GraphPad Prism 6.0 software (GraphPad Software Inc., San Diego, CA, USA), followed by comparison of means (one-way ANOVA) using Dunnett’s multiple comparisons test, at the significance level of p < 0.05.

5. Conclusions

The composition of Artemisia herba-alba and Origanum majorana essential oils growing in Morocco was analyzed and its antibacterial and antifungal activity investigated. The results indicated an important antimicrobial activity against different microorganisms especially from O. majorana essential oil. Thus, they can maybe be applied in food industry as natural preservatives, due to their antibacterial properties. Further organoleptic features and toxicological studies are required to prove the safety of the oils.
  12 in total

1.  Chemical composition and fumigant toxicity of some essential oils against Ephestia kuehniella.

Authors:  Salih Karabörklü; Abdurrahman Ayvaz; Semih Yilmaz; Mikail Akbulut
Journal:  J Econ Entomol       Date:  2011-08       Impact factor: 2.381

2.  Chemical composition and in vitro evaluation of antioxidant, antimicrobial, cytotoxicity and anti-acetylcholinesterase properties of Tunisian Origanum majorana L. essential oil.

Authors:  Hafedh Hajlaoui; Hedi Mighri; Mahjoub Aouni; Néji Gharsallah; Adel Kadri
Journal:  Microb Pathog       Date:  2016-03-17       Impact factor: 3.738

3.  Antimicrobial agents from plants: antibacterial activity of plant volatile oils.

Authors:  H J Dorman; S G Deans
Journal:  J Appl Microbiol       Date:  2000-02       Impact factor: 3.772

4.  Valorization of essential oils from Moroccan aromatic plants.

Authors:  Omar Santana; Maria Fe Andrés; Jesús Sanz; Naima Errahmani; Lamiri Abdeslam; Azucena González-Coloma
Journal:  Nat Prod Commun       Date:  2014-08       Impact factor: 0.986

5.  Chemical composition and biological activities of the essential oil from Artemisia herba-alba growing wild in Tunisia.

Authors:  Ismail Amri; Laura De Martino; Aurelio Marandino; Hamrouni Lamia; Hanana Mohsen; Elia Scandolera; Vincenzo De Feo; Emilia Mancini
Journal:  Nat Prod Commun       Date:  2013-03       Impact factor: 0.986

6.  Antimicrobial and Phytotoxic Activity of Origanum heracleoticum and O. majorana Essential Oils Growing in Cilento (Southern Italy).

Authors:  Teresa Della Pepa; Hazem S Elshafie; Raffaele Capasso; Vincenzo De Feo; Ippolito Camele; Filomena Nazzaro; Maria Rosa Scognamiglio; Lucia Caputo
Journal:  Molecules       Date:  2019-07-16       Impact factor: 4.411

Review 7.  Efficacy of Iranian traditional medicine in the treatment of epilepsy.

Authors:  Mehri Abdollahi Fard; Asie Shojaii
Journal:  Biomed Res Int       Date:  2013-07-07       Impact factor: 3.411

8.  Effect of essential oils on pathogenic bacteria.

Authors:  Filomena Nazzaro; Florinda Fratianni; Laura De Martino; Raffaele Coppola; Vincenzo De Feo
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-25

9.  Essential oil composition of Artemisia herba-alba from southern Tunisia.

Authors:  Haouari Mohsen; Ferchichi Ali
Journal:  Molecules       Date:  2009-04-20       Impact factor: 4.411

10.  Essential oils from Taiwan: Chemical composition and antibacterial activity against Escherichia coli.

Authors:  Po-Chen Lin; Jason Jwo Lee; I-Jy Chang
Journal:  J Food Drug Anal       Date:  2016-04-11       Impact factor: 6.157

View more
  9 in total

1.  Antimicrobial, Multidrug Resistance Reversal and Biofilm Formation Inhibitory Effect of Origanum majorana Extracts, Essential Oil and Monoterpenes.

Authors:  Tasneem Sultan Abu Ghazal; Zsuzsanna Schelz; Lívia Vidács; Nikoletta Szemerédi; Katalin Veres; Gabriella Spengler; Judit Hohmann
Journal:  Plants (Basel)       Date:  2022-05-27

2.  Basil Essential Oil: Composition, Antimicrobial Properties, and Microencapsulation to Produce Active Chitosan Films for Food Packaging.

Authors:  Ghita Amor; Mohammed Sabbah; Lucia Caputo; Mohamed Idbella; Vincenzo De Feo; Raffaele Porta; Taoufiq Fechtali; Gianluigi Mauriello
Journal:  Foods       Date:  2021-01-08

3.  Effect of Physical and Chemical Treatments on Viability, Sub-Lethal Injury, and Release of Cellular Components from Bacillus clausii and Bacillus coagulans Spores and Cells.

Authors:  Antonio Bevilacqua; Leonardo Petruzzi; Milena Sinigaglia; Barbara Speranza; Daniela Campaniello; Emanuela Ciuffreda; Maria Rosaria Corbo
Journal:  Foods       Date:  2020-12-07

4.  Antifungal and Anti-Virulent Activity of Origanum majorana L. Essential Oil on Candida albicans and In Vivo Toxicity in the Galleria mellonella Larval Model.

Authors:  Banu Kaskatepe; Sinem Aslan Erdem; Sukran Ozturk; Zehra Safi Oz; Eldan Subasi; Mehmet Koyuncu; Josipa Vlainić; Ivan Kosalec
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

Review 5.  Artemisia spp.: An Update on Its Chemical Composition, Pharmacological and Toxicological Profiles.

Authors:  Javad Sharifi-Rad; Jesús Herrera-Bravo; Prabhakar Semwal; Sakshi Painuli; Himani Badoni; Shahira M Ezzat; Mai M Farid; Rana M Merghany; Nora M Aborehab; Mohamed A Salem; Surjit Sen; Krishnendu Acharya; Natallia Lapava; Miquel Martorell; Bekzat Tynybekov; Daniela Calina; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2022-09-05       Impact factor: 7.310

Review 6.  Chemical Composition, Enantiomeric Distribution, Antimicrobial and Antioxidant Activities of Origanum majorana L. Essential Oil from Nepal.

Authors:  Prem Narayan Paudel; Prabodh Satyal; Rakesh Satyal; William N Setzer; Rajendra Gyawali
Journal:  Molecules       Date:  2022-09-19       Impact factor: 4.927

7.  Phytochemical Profile and In Vitro Antioxidant, Antimicrobial, Vital Physiological Enzymes Inhibitory and Cytotoxic Effects of Artemisia jordanica Leaves Essential Oil from Palestine.

Authors:  Nidal Jaradat
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

8.  Origanum majorana Essential Oil Triggers p38 MAPK-Mediated Protective Autophagy, Apoptosis, and Caspase-Dependent Cleavage of P70S6K in Colorectal Cancer Cells.

Authors:  Khawlah Athamneh; Aysha Alneyadi; Halima Alsamri; Asma Alrashedi; Abdulrasheed Palakott; Khaled A El-Tarabily; Ali H Eid; Yusra Al Dhaheri; Rabah Iratni
Journal:  Biomolecules       Date:  2020-03-06

9.  Aqueous Extract of Origanum majorana at Low Temperature (0°C) Promotes Mitochondrial Fusion and Contributes to Induced Apoptosis in Human Breast Cancer Cells.

Authors:  Asma Algebaly; Qwait AlGabbani; Wedad Refaiea Al-Otaibi; Amani Mohammed Alotaibi; Fatimah Gh Albani; Ibtesam Sanad ALanazi; Gadah Albasher; Abdul Qader Saeed Alqahtani; Wedad Saeed Al-Qahtani
Journal:  Asian Pac J Cancer Prev       Date:  2021-09-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.